Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice

Yiduo Hu1, Xincheng Lu, Guangbin Luo

  • 1Department of Genetics, Case Comprehensive Cancer Center and University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH 44106, USA.

Abstract

Insights

Recql5 deficiency significantly increases gastrointestinal tumors in mice. This DNA helicase acts as a tumor suppressor in the mouse gut, suggesting a similar role for human RECQL5 in colon cancer.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Recql5 is a DNA helicase crucial for maintaining genome stability.
  • Its role as a tumor suppressor in the gastrointestinal tract is not well understood.

Purpose of the Study:

  • To investigate the tumor suppressive function of Recql5 in the mouse gastrointestinal tract.
  • To determine if Recql5 deficiency influences tumor susceptibility in a mouse model of intestinal cancer.

Main Methods:

  • Generated Recql5-proficient and Recql5-deficient Apc(min/+) mice.
  • Compared tumor incidence in the gastrointestinal tracts of these mouse cohorts.

Main Results:

  • Recql5 deficiency led to a significant increase in tumor incidence in both the colon and small intestine of Apc(min/+) mice.
  • These results provide the first genetic evidence for Recql5's tumor suppressor role in the mouse gastrointestinal tract.
  • Given the high conservation between mouse Recql5 and human RECQL5, these findings suggest a potential tumor suppressor role for RECQL5 in human colon cancer.

Conclusions:

  • Recql5 functions as a tumor suppressor in the mouse gastrointestinal tract.
  • This study highlights the importance of Recql5 in preventing gastrointestinal cancers.

Related Concept Videos